CACI International Inc · CACI · FY2026 Q1 · Calendar Q4 2025
CACI maintains FY26 outlook as Counter-UAS and modernization demand build
CACI's Q1 results support a constructive operating trajectory: revenue growth, contract wins, backlog, and demand for Counter-UAS and modernization programs underpinned maintained FY26 guidance. The thesis is conditional because shutdown effects, reconciliation-funding timing, booking volatility, and competition could interrupt execution.
Earnings scorecard
Reported versus consensusMarket reaction
event-close to next-session closeAsk FN2 about CACI FY2026 Q1
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior quarter, CACI's analysis highlighted a $5 billion Q1 contract-win figure, a 2.2x book-to-bill ratio, a $34 billion backlog, follow-on Canadian Counter-UAS orders, and increased transparency into intelligence-community revenue. Management also emphasized commercial-style procurement and AI-enhanced software development, while adding shutdown-related cash-flow and booking risks.
Guidance delta
Management maintained FY26 guidance for $9.2-$9.4 billion of revenue, a mid-11% EBITDA margin, and at least $710 million of free cash flow.
Key takeaways
- Q1 FY26 revenue grew 11% year over year, with an 11.7% EBITDA margin and $143 million of free cash flow.
- CACI reported $5 billion of contract wins, a 2.2x book-to-bill ratio, and a $34 billion backlog covering about four years of revenue.
- Management highlighted Counter-UAS, Counter-Space, network modernization, international sales, and commercial-style procurement as growth supports.
- A government shutdown could delay cash collections and modestly pressure revenue, while reconciliation-funding timing remains a variable.
Management priorities
- Continue development and fielding of the Merlin Counter-UAS system and related variants.
- Use AI tools to accelerate agile software development and product updates.
- Pursue Golden Dome and other reconciliation-funded Counter-Space opportunities.
- Expand international sales through licensing and co-production with NATO partners.
- Integrate recent acquisitions and evaluate additional M&A in sensors and software.
Follow CACI with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 24, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| UBS | Buy | Buy | Maintain | Oct 23, 2026 |
| Stifel | Buy | Buy | Maintain | Oct 23, 2026 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Oct 21, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Oct 7, 2026 |
| BNP Paribas | Underperform | Neutral | Downgrade | Oct 6, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Aug 7, 2026 |
| TD Cowen | Buy | Buy | Maintain | Jul 7, 2026 |
| Jefferies | Hold | Hold | Maintain | Jul 1, 2026 |
| Truist Securities | Buy | Buy | Maintain | Nov 14, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Oct 27, 2025 |
| Raymond James | Market Perform | Outperform | Downgrade | Jul 8, 2025 |
| William Blair | Outperform | Market Perform | Upgrade | Jul 7, 2025 |
| Barclays | Overweight | Overweight | Maintain | Apr 29, 2025 |
| Wells Fargo | Overweight | Overweight | Maintain | Apr 28, 2025 |
| Baird | Outperform | Outperform | Maintain | Jan 14, 2025 |
| B of A Securities | Buy | Buy | Maintain | Sep 17, 2024 |
| Morgan Stanley | Overweight | Overweight | Maintain | Feb 2, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Jan 29, 2021 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Apr 14, 2020 |
| Stifel Nicolaus | Buy | Buy | Maintain | Jan 30, 2020 |
| Citi | Neutral | Buy | Downgrade | Jul 9, 2019 |
| Noble Financial | Hold | Buy | Downgrade | Aug 17, 2018 |
| Noble Capital Markets | Hold | Buy | Downgrade | Aug 17, 2018 |
| B. Riley Securities | Neutral | Neutral | Maintain | Aug 17, 2018 |
| B. Riley FBR | Neutral | Neutral | Maintain | Aug 17, 2018 |
| Maxim Group | Buy | Buy | Maintain | Feb 2, 2018 |
| Loop Capital | Buy | Hold | Upgrade | Feb 1, 2018 |
| Cowen & Co. | Outperform | Market Perform | Upgrade | Jun 12, 2017 |
| BB&T Capital | Buy | Hold | Upgrade | Dec 17, 2015 |
| RBC Capital | Sector Perform | Underperform | Upgrade | Mar 18, 2014 |
Named analyst price targets
Upside is calculated against the persisted current price $633.98. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Gavin Parsons | $823 | $625.38 | +29.8% | Oct 23, 2026 |
| Stifel Nicolaus | Jonathan Siegmann | $925 | $625.91 | +45.9% | Oct 23, 2026 |
| Cantor Fitzgerald | Colin Canfield | $785 | $607.75 | +23.8% | Oct 21, 2026 |
| Macquarie | Analyst unavailable | $780 | $611.36 | +23.0% | Oct 16, 2026 |
| Wells Fargo | Analyst unavailable | $715 | $644.43 | +12.8% | Aug 10, 2026 |
| Jefferies | Analyst unavailable | $700 | $644.43 | +10.4% | Aug 9, 2026 |
| UBS | Analyst unavailable | $804 | $628.79 | +26.8% | Aug 7, 2026 |
| Stifel Nicolaus | Analyst unavailable | $892 | $644.93 | +40.7% | Aug 6, 2026 |
| Cantor Fitzgerald | Colin Canfield | $675 | $459.77 | +6.5% | Jul 22, 2026 |
| Jefferies | Analyst unavailable | $510 | $464.32 | -19.6% | Jul 1, 2026 |
| BNP Paribas | Analyst unavailable | $550 | $510.46 | -13.2% | May 27, 2026 |
| Jefferies | Sheila Kahyaoglu | $550 | $516.54 | -13.2% | Apr 26, 2026 |
| UBS | Gavin Parsons | $787 | $655.46 | +24.1% | Jan 23, 2026 |
| Stifel Nicolaus | Analyst unavailable | $765 | $655.46 | +20.7% | Jan 22, 2026 |
| Truist Financial | Tobey Sommer | $800 | $654.36 | +26.2% | Jan 22, 2026 |
| UBS | Analyst unavailable | $752 | $609.86 | +18.6% | Jan 15, 2026 |
| Goldman Sachs | Noah Poponak | $624 | $585.55 | -1.6% | Oct 27, 2025 |
| UBS | Gavin Parsons | $759 | $584.57 | +19.7% | Oct 24, 2025 |
| Stifel Nicolaus | Analyst unavailable | $670 | $584.57 | +5.7% | Oct 23, 2025 |
| Truist Financial | Analyst unavailable | $600 | $584.57 | -5.4% | Oct 23, 2025 |
| Truist Financial | Tobey Sommer | $575 | $495.17 | -9.3% | Aug 8, 2025 |
| Wells Fargo | Matthew Akers | $513 | $448.82 | -19.1% | Apr 28, 2025 |
| Truist Financial | Tobey Sommer | $525 | $447.26 | -17.2% | Apr 25, 2025 |
| Truist Financial | Tobey Sommer | $475 | $424.05 | -25.1% | Apr 14, 2025 |
| Jefferies | Analyst unavailable | $455 | $372.7 | -28.2% | Mar 25, 2025 |
| Robert W. Baird | Peter Arment | $540 | $413.95 | -14.8% | Jan 14, 2025 |
| Raymond James | Brian Gesuale | $475 | $402.72 | -25.1% | Jan 2, 2025 |
| Barclays | David Strauss | $450 | $414 | -29.0% | Dec 12, 2024 |
| UBS | Gavin Parsons | $557 | $459.88 | -12.1% | Dec 2, 2024 |
| Barclays | David Strauss | $625 | $560.92 | -1.4% | Nov 11, 2024 |
| Jefferies | Sheila Kahyaoglu | $570 | $563.36 | -10.1% | Oct 30, 2024 |
| Barclays | David Strauss | $610 | $547.78 | -3.8% | Oct 29, 2024 |
| Truist Financial | Tobey Sommer | $520 | $478.3 | -18.0% | Sep 5, 2024 |
| Bank of America Securities | Mariana Perez Mora | $535 | $471.02 | -15.6% | Aug 27, 2024 |
| Robert W. Baird | Peter Arment | $544 | $460.66 | -14.2% | Aug 9, 2024 |
| Stifel Nicolaus | Bert Subin | $500 | $425.6 | -21.1% | Jul 1, 2024 |
| Wells Fargo | Matthew Akers | $468 | $402.23 | -26.2% | Apr 30, 2024 |
| Stifel Nicolaus | Bert Subin | $440 | $397.12 | -30.6% | Apr 25, 2024 |
| Stifel Nicolaus | Bert Subin | $430 | $376.08 | -32.2% | Apr 22, 2024 |
| Morgan Stanley | Analyst unavailable | $357 | $305.39 | -43.7% | Feb 2, 2023 |
| Morgan Stanley | Analyst unavailable | $355 | $305 | -44.0% | Jan 3, 2023 |
| Morgan Stanley | Analyst unavailable | $325 | $304.86 | -48.7% | Dec 14, 2022 |
| Barclays | Analyst unavailable | $340 | $281.19 | -46.4% | Apr 25, 2022 |
| Goldman Sachs | Gavin Parsons | $316 | $260.01 | -50.2% | Jun 8, 2021 |
Track every rating change on CACI the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationCACI International Inc, alongside its subsidiaries, is a provider of specialized expertise and advanced technology. The company primarily serves enterprise and mission-critical customers by supporting vital national security objectives and facilitating government modernization and transformation efforts across the intelligence, defense, and federal civilian sectors. The company operates through two main divisions: Domestic Operations and International Operations. The Domestic Operations segment focuses on delivering information solutions and services to U.S. federal government agencies and commercial entities. This includes areas such as digital transformation, Command, Control, Communications, Computers, Intelligence, Surveillance, and Reconnaissance (C4ISR), cybersecurity and space technologies, engineering services, enterprise IT management, and mission support.…
Historical context
All CACI earningsTechnology peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| INFY Infosys Limited | FY2027 Q2 · Calendar Q4 2026 | -4.8% | -6.6% | Infosys trims growth outlook as AI revenue and deal wins accelerate |
| SSNC SS&C Technologies Holdings, Inc. | FY2026 Q3 · Calendar Q4 2026 | +0.6% | +2.8% | SS&C raises 2026 outlook as AI and tokenization support growth |
| ROP Roper Technologies, Inc. | FY2026 Q3 · Calendar Q4 2026 | +1.7% | +9.7% | Roper raises DEPS outlook as AI adoption expands across portfolio |
| VRSN VeriSign, Inc. | FY2026 Q3 · Calendar Q4 2026 | -2.0% | -0.9% | VeriSign reports record registrations as renewal mix becomes a key watchpoint |
| TTMI TTM Technologies, Inc. | FY2026 Q3 · Calendar Q4 2026 | +16.8% | -27.7% | TTM Technologies Q3: Record Growth, Higher Investment, More Deal Risk |
| NOK Nokia Oyj | FY2026 Q3 · Calendar Q4 2026 | +25.0% | -14.8% | Nokia Q3: AI and cloud growth lifts margins as cash flow stays negative |
Latest beats and misses
Who reports nextBeat on EPS
- RDYFY2027 Q2 · October 23, 2026+24.0% EPS-0.2% move
- SLBFY2026 Q3 · October 23, 2026+3.7% EPS+7.1% move
- AXPFY2026 Q3 · October 23, 2026+4.0% EPS-3.7% move
- RCIFY2026 Q3 · October 23, 2026+9.5% EPS-2.4% move
- EFY2026 Q3 · October 23, 2026+13.9% EPS+4.3% move
- RITM-PDFY2026 Q3 · October 23, 2026+10.2% EPS— move
Missed on EPS
- INFYFY2027 Q2 · October 23, 2026-4.8% EPS-6.6% move
- BBDFY2026 Q3 · October 22, 2026-7.7% EPS+3.0% move
- SNAFY2026 Q3 · October 22, 2026-5.9% EPS-3.4% move
- SPOTFY2026 Q3 · October 22, 2026-11.6% EPS+11.1% move
- VRSNFY2026 Q3 · October 22, 2026-2.0% EPS-0.9% move
- HBANMFY2026 Q3 · October 22, 2026-5.3% EPS+0.5% move
Get the CACI recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-10-24T03:30:42.743064+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-24T03:30:42.740276+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-24. For educational purposes only; not investment advice.